online cancer risk assessment for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Breast Cancer+5 Moreonline cancer risk assessment - Other
Eligibility
25 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare three methods for identifying and risk-stratifying individuals at risk of hereditary cancer, and providing post-risk stratification longitudinal care.

Eligible Conditions
  • Breast Cancer
  • Colorectal Cancer
  • Family History
  • Lynch Syndrome
  • Ovarian Cancer
  • Genetic Predisposition

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 0 to 12 months

0 to 12 months
Number of patients identified at high risk of cancer

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Comparator 2
1 of 2
Comparator 3
1 of 2

Experimental Treatment

18000 Total Participants · 2 Treatment Groups

Primary Treatment: online cancer risk assessment · No Placebo Group · N/A

Comparator 2
Other
Experimental Group · 1 Intervention: online cancer risk assessment · Intervention Types: Other
Comparator 3
Other
Experimental Group · 1 Intervention: online cancer risk assessment · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 0 to 12 months

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
508 Previous Clinical Trials
22,237,348 Total Patients Enrolled
7 Trials studying Breast Cancer
3,728,846 Patients Enrolled for Breast Cancer
Patient-Centered Outcomes Research InstituteOTHER
493 Previous Clinical Trials
29,812,195 Total Patients Enrolled
7 Trials studying Breast Cancer
1,480,210 Patients Enrolled for Breast Cancer
Douglas Corley, MD, PhDPrincipal InvestigatorDivision of Research, Kaiser Permanente Northern California

Eligibility Criteria

Age 25 - 75 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
to receive the study medication People who are adults, have been members for at least two years, have had at least one clinical visit in the past two years, and have a listed email address are eligible to receive the study medication.
People who want to be in the study must have received medical care within the past two years at one of the Kaiser Permanente Northern California locations that are being studied.